COLL FY 2021 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena

COLLCollegium Pharmaceutical, Inc.

$1B

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$277M-10.7% YoY

Gross Profit

$151M54.4% margin

Operating Income

$18M6.4% margin

Net Income

$72M25.8% margin

EPS (Diluted)

$1.86

Cash Flow

Operating Cash Flow

$104M

Free Cash Flow

$102M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$692M

Total Liabilities

$489M

Stockholders' Equity

$203M

Cash & Equivalents

$186M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$277M	$310M	-10.7%
Gross Profit	$151M	$180M	-16.2%
Operating Income	$18M	$56M	-68.7%
Net Income	$72M	$27M	+167.3%